Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Childrens Place, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2024
FY2024
FY2025
Revenue
1,785
1,870
1,938
1,871
1,523
1,915
1,708
1,603
1,386
1,209
Cost of revenue
1,114
1,159
1,254
1,215
1,189
1,121
1,194
1,157
927
847
Gross profit
672
711
684
655
333
795
514
445
459
362
Selling, general and administrative
454
476
498
478
428
459
461
447
406
384
Operating income
147
162
111
96.4
-200
276
-1.53
-83.8
-13.7
-57.2
Interest expense
-1.95
-2.22
-3.53
8.19
11.9
18.6
13.3
30.1
Interest income
0.25
0.06
0.02
0.09
0.09
0.05
0.05
Pre-tax income
147
161
109
88.4
-212
257
-14.8
-114
-49.4
-90.3
Income tax
44.7
76.5
7.56
15.1
-71.4
69.9
-13.6
40.7
8.37
-2.02
Net income
102
84.7
101
73.3
-140
187
-1.14
-155
-57.8
-88.3
EBITDA
213
230
180
171
-134
334
49.9
-36.6
25.9
-24.1
EPS, basic
4.71
-9.59
12.82
-0.09
-12.34
-4.53
-4.01
EPS, diluted
4.68
-9.59
12.59
-0.09
-12.34
-4.53
-4.01
Shares, basic (weighted)
18.6
17.6
16.5
15.5
14.6
14.6
13.1
12.5
12.8
22
Shares, diluted (weighted)
19
18.2
16.8
15.7
14.6
14.9
13.1
12.5
12.8
22
Dividend per share
2.24
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2024
FY2024
FY2025
Cash and equivalents
194
245
69.1
68.5
63.5
54.8
16.7
13.6
5.35
5.49
Short-term investments
49.3
15
0
Receivables
31.4
26.1
35.1
32.8
39.5
21.9
49.6
33.2
42.7
26
Inventory
286
324
303
327
388
429
448
362
400
325
Other current assets
32.9
46.5
27.7
21.4
5.56
9.46
5.05
3.83
2.57
4.3
Total current assets
611
657
435
450
547
582
562
452
468
398
Property, plant and equipment
264
259
260
237
182
155
150
125
97.5
81.7
Lease right-of-use assets
0
394
284
195
155
175
162
164
Intangible assets
0
73.3
73.7
71.9
70.9
41.1
13
13
Other non-current assets
5.32
12.5
13.5
14.6
9.55
11.5
11.5
6.96
7.47
13.1
Total assets
910
940
727
1,181
1,140
1,037
986
800
748
670
Accounts payable
178
210
195
213
252
184
177
226
127
108
Accrued liabilities
122
122
86.8
83.6
117
131
99.7
89.6
75.9
88.1
Deferred revenue
3.13
3.8
2.18
1.9
5.3
4.61
3.95
4.83
4.18
6.95
Short-term debt
15.4
21.5
48.9
0
2.27
0
287
227
246
0
Total current liabilities
329
361
331
595
718
592
648
616
518
388
Lease liabilities
0
312
214
135
96.5
118
107
120
Other non-current liabilities
16.5
15
12.9
14.9
17.5
12.1
13.2
10.9
10.3
7.52
Total liabilities
414
467
413
946
1,047
812
828
809
807
724
Total debt
0
75.3
49.7
49.8
49.8
166
Paid-in capital
240
259
147
139
149
160
151
141
151
243
Retained earnings
275
226
181
108
-42.8
77.9
22.5
-135
-193
-281
Treasury stock
-2.19
-2.44
-2.69
-2.96
-3.16
-3.44
-3.74
-2.91
-0.09
-0.07
Other comprehensive income
-13.8
-14.2
-16.2
-16.5
-19.5
-18.2
Shareholders' equity
314
235
93.4
225
158
-9.02
-59.4
-54.2
Total equity
496
474
314
235
93.4
225
158
-9.02
-59.4
-54.2
Total liabilities and equity
910
940
727
1,181
1,140
1,037
986
800
748
670
Shares outstanding
17.7
17.2
15.8
14.7
14.6
13.9
12.2
12.5
12.8
22.2
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2024
FY2024
FY2025
Net income
102
84.7
101
73.3
-140
187
-1.14
-155
-57.8
-88.3
Depreciation and amortization
65.7
68.2
68.9
74.8
66.4
58.4
51.5
47.2
39.6
33.1
Stock-based compensation
28
30.8
27.4
16.2
14.3
30.9
29.2
-5.58
12.8
2.99
Deferred income tax
-9.38
34.9
-5.57
5.36
-32.3
25.8
-13.7
37
0
-0.58
Change in receivables
5.06
-5.39
9.13
-3.15
3.62
Change in inventory
-16.1
-36.4
19.4
-23.5
-61.1
-40.9
-20.7
85.3
-38.3
75.9
Change in payables
19
28.9
-56.9
17.5
71.7
-58.3
-41.7
40
-108
-12
Cash from operations
199
214
140
178
-35.7
133
-8.22
92.8
-118
8.12
Capital expenditures
-34.7
-58.7
-71.1
-57.5
-30.6
-29.3
-45.6
-27.6
-15.8
-17.4
Purchases of investments
-49.3
-15
0
0
Cash from investing
-44.3
-25.1
-56.9
-134
-30.4
-29.3
-45.9
-27.8
-15.8
-17.4
Stock issued
0.44
0
0
Share buybacks
-158
-119
-254
-131
-15.5
-84
-94.6
-7.13
-0.67
-0.42
Dividends paid
-14.8
-28.1
-33
-34.9
0
0
0
0
-1.69
Cash from financing
-155
-141
-259
-44.4
60.9
-113
17.1
-68.3
128
6.97
Exchange rate effect
6.18
2.17
0.75
0.17
0.22
-0.01
-0.99
0.21
-3.27
2.44
Net change in cash
6.18
50.8
-175
-0.65
-4.94
-8.76
-38.1
-3.05
-8.29
0.14
Free cash flow
165
156
68.8
120
-66.3
104
-53.8
65.2
-133
-9.26
Interest paid
-1.68
-1.95
-3.22
7.55
10.8
14.8
12.4
29
27
28.7
Income taxes paid
-31.5
-37.8
-19.5
1.31
3.64
49.6
-15
5.78
-1.73
16
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $2.16 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
29.0%
Gross profit / revenue.
Operating margin
-8.2%
Operating income / revenue.
EBITDA margin
-5.5%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-12.2%
Pre-tax income / revenue.
Net margin
-11.8%
Net income / revenue.
FCF margin
2.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
4.4%
Cash from operations / revenue.
Return on assets (ROA)
-17.9%
Net income / average total assets.
SG&A / revenue
34.3%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
-0.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.3%
Capital expenditures / revenue.
D&A / revenue
2.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-12.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-10.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-4.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-21.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-11.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
1.6%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y
-193.2%
EBITDA vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-10.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-12.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-10.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
72.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
19.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
8.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.89x
Current assets / current liabilities.
Quick ratio
0.11x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.01x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
53.3%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$5.98
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$50.62
Revenue / diluted weighted shares.
FCF per share
$1.04
Free cash flow / diluted weighted shares.
Operating cash flow per share
$2.22
Cash from operations / diluted weighted shares.
Book value per share
-$6.25
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Share buybacks / free cash flow, when free cash flow is positive.
Valuation
Metric
Value
How it is calculated
Market cap
$48.0M
Share price x shares outstanding.
Enterprise value
$40.9M
Market cap + total debt - cash - short-term investments.
P/S
0.04x
Market cap / revenue.
P/FCF
2.09x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
0.98x
Market cap / cash from operations, when positive.
EV/Sales
0.04x
Enterprise value / revenue.
EV/FCF
1.77x
Enterprise value / free cash flow, when both are positive.
FCF yield
47.9%
Free cash flow / market cap.
Earnings yield
-276.9%
Net income / market cap (the inverse of P/E).
Shareholder yield
0.1%
(Dividends paid + share buybacks) / market cap.
What was Childrens Place, Inc.'s revenue in fiscal 2025?
Childrens Place, Inc. reported revenue of $1.21B for fiscal 2025, 12.8% lower than the year before.
Was Childrens Place, Inc. profitable in fiscal 2025?
No. It reported a net loss of $88.3M.
How much free cash flow did Childrens Place, Inc. generate in fiscal 2025?
Cash from operations of $8.1M minus capital expenditures of $17.4M left free cash flow of -$9.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.